Table 1

Schedule of interventions and assessments

Study period
(16 weeks to 8 weeks postdelivery)
Study visitTrial entry/baselineAntenatal follow-upNotes reviewPostnatal follow-up
Time point20±4
weeks gestation
30±3
weeks
gestation
40+4
weeks (postdelivery)
40+8
weeks (postdelivery)
Informed consentX
Eligibility assessmentX
Demographics; including age, race, educationX
Maternal demographics; including gestation, EDD and parityX
Patient Questionnaires; including EQ-5D-5L and STAIXXX
RandomisationX
Recording home BPSelf-Monitoring group will record and submit reading between baseline and delivery
Recording clinic BPsX
Maternal and perinatal outcomesX
Secondary outcome dataX
Return of BP monitorBP monitors will be returned at/or postdelivery
  • BP, blood pressure; EDD, Estimated Delivery Date; EQ-5D-5L, EuroQoL 5 Dimensions 5 Levels; STAI, State-Trait Anxiety Inventory.